William Blair
http://www.williamblair.comWilliam Blair & Company, L.L.C. is a Chicago-based investment firm offering investment banking, asset management, equity research, institutional and private brokerage, and private capital to individual, institutional, and issuing clients. Since 1935, it has been committed to helping clients achieve their financial objectives.
View Older Stories View More Recent Stories
-
Form NPORT-P WILLIAM BLAIR FUNDS For: Jun 30
-
Form NPORT-P WILLIAM BLAIR FUNDS For: Jun 30
-
Form NPORT-P WILLIAM BLAIR FUNDS For: Jun 30
-
Form NPORT-P WILLIAM BLAIR FUNDS For: Jun 30
-
Form NPORT-P WILLIAM BLAIR FUNDS For: Jun 30
-
Form NPORT-P WILLIAM BLAIR FUNDS For: Jun 30
-
Form NPORT-P WILLIAM BLAIR FUNDS For: Jun 30
-
Form NPORT-P WILLIAM BLAIR FUNDS For: Jun 30
-
Form NPORT-P WILLIAM BLAIR FUNDS For: Jun 30
-
Form NPORT-P WILLIAM BLAIR FUNDS For: Jun 30
-
Form NPORT-P WILLIAM BLAIR FUNDS For: Jun 30
-
Form NPORT-P WILLIAM BLAIR FUNDS For: Jun 30
-
Form NPORT-P WILLIAM BLAIR FUNDS For: Jun 30
-
Form NPORT-P WILLIAM BLAIR FUNDS For: Jun 30
-
Form NPORT-P WILLIAM BLAIR FUNDS For: Jun 30
-
KKR prices secondary offering of 5 million BridgeBio shares
-
KKR to sell 5 million BridgeBio shares in secondary offering
-
Savers Value Village closes 23M share secondary offering
-
William Blair Downgrades Accelerant Holdings (ARX) to Market Perform
-
Form 13F-HR WILLIAM BLAIR INVESTMENT For: Jun 30
-
William Blair Downgrades Cardiff Oncology (CRDF) to Market Perform
-
Silence Therapeutics prices $175 million public offering at $13.50 per ADS
-
Savers Value Village prices $205M secondary stock offering
-
Form SCHEDULE 13G Revolve Group, Inc. Filed by: WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC
-
Form SCHEDULE 13G/A Twist Bioscience Corp Filed by: WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC
-
Form SCHEDULE 13G/A i3 Verticals, Inc. Filed by: WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC
-
William Blair Downgrades On Holding AG (ONON) to Market Perform
-
Form 13F-HR BLAIR WILLIAM & CO/IL For: Jun 30
-
William Blair Assumes Applied Materials (AMAT) at Market Perform
-
On Holding Q2 seen holding strong as spending data counters July search slowdown
-
Silence Therapeutics launches $150 million ADS public offering
-
Silence Therapeutics Announces Proposed Public Offering of $150 Million of American Depositary Shares
-
William Blair Downgrades Tenax Therapeutics (TENX) to Market Perform
-
Lyntris launches IPO at $19-$22 per share on NYSE
-
Lyntris Inc. Announces Launch of its Initial Public Offering
-
William Blair Starts Standard Nuclear (STDN) at Outperform
-
William Blair cites tight labor market in staffing stock outlook
-
KKR closes equity investment in Crowe Advisory LLC
-
Crowe closes strategic investment from KKR
-
Remitly Announces Upcoming Webinar and Investor Conference Participation
-
William Blair Upgrades Dropbox (DBX) to Market Perform
-
Abry Partners Exits Investment in Prime Capital Financial Following Period of Significant Growth
-
Carlyle takes minority stake in Prime Capital Financial at $1.8B value
-
Prime Capital Financial Announces Strategic Partnership With Carlyle to Accelerate Next Phase of Growth
-
William Blair Downgrades EPAM Systems (EPAM) to Market Perform
-
William Blair Downgrades Zoetis Inc. (ZTS) to Market Perform, 'Changing Commercial Strategies Create Too Much Uncertainty on the P&L'
-
Tarsus Pharmaceuticals raises $125M in oversubscribed PIPE financing
-
Tarsus Pharmaceuticals Announces Oversubscribed $125.0 Million Private Placement Equity Financing
-
William Blair Downgrades LegalZoom.com Inc (LZ) to Market Perform
-
William Blair Positive on Axon Enterprise (AXON): 'ARR Shows Acceleration to 39% Growth Supported by 41% FCB Growth'
